The Mobility Directive EU 2019/2121 aims to harmonize cross-border conversions and amends the regime applicable to cross-border mergers and divisions. Its transposition was due on 31 January 2023. Germany and Luxembourg are currently in the final stages of adopting the relevant national laws.
As of 2023, companies envisaging corporate restructurings should prepare for a new regime applicable to mergers, migrations and conversions. While Luxembourg will apply the changes proposed by the Mobility Directive only to cross-border restructurings in scope, Germany has opted to extend its reform also to national conversions.
The GSK Update provides an detailed overview of the Mobility Directive.
Press contact
presse@gsk.de
+49 30 203907-7763
Dr. Marcel Vietor
Partner*
+49 89 288174-74
marcel.vietor@gsk.de
Yannick Stahl
Senior Associate
+49 89 288174-74
yannick.stahl@gsk.de
Anna Lindner
Local Partner
+352 271802-43
anna.lindner@gsk-lux.com
Andrea Carraretto, LL.M.
Senior Associate
+352 271802-42
andrea.carraretto@gsk-lux.com
For reasons of better readability, we use the gender-neutral generic masculine. However, the information expressly refers to all genders.
